Evidence map›Paper›PMID 40698047›Full record

ArticleFrontiers in psychiatry2025

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.

Rocío Gómez-Ballesteros, Susana Sainz de la Maza, Mónica Borges, Jesús Martín-Martínez, Javier Sotoca, Ana Alonso, Ana B Caminero, Laura Borrega, José L Sánchez-Menoyo, Francisco J Barrero-Hernández and 14 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Rocío Gómez-BallesterosMedical Department, Roche Farma, Madrid, Spain.
Susana Sainz de la MazaDepartment of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Mónica BorgesDepartment of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Jesús Martín-MartínezDepartment of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Javier SotocaDepartment of Neurology, Hospital Universitari Mútua Terrassa, Terrassa, Spain.
Ana AlonsoDepartment of Neurology, Hospital Regional Universitario de Málaga, Málaga, Spain.
Ana B CamineroDepartment of Neurology, Complejo Asistencial de Ávila, Ávila, Spain.
Laura BorregaDepartment of Neurology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
José L Sánchez-MenoyoDepartment of Neurology, Hospital de Galdakao-Usansolo, Galdakao, Spain.
Francisco J Barrero-HernándezDepartment of Neurology, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Carmen CallesDepartment of Neurology, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
Luis BrievaDepartment of Neurology, Hospital Arnau de Vilanova de Lleida, UdL Medicine Department, Instituto de Investigación Biomédica de Lleida (IRBLleida), Lleida, Spain.
María R Blasco-QuílezDepartment of Neurology, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Julio Dotor García-SotoDepartment of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Ana Rodríguez-RegalDepartment of Neurology, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
Laura Navarro-CantóDepartment of Neurology, Hospital General Universitario de Elche, Elche, Spain.
Eduardo AgüeraDepartment of Neurology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Moisés Garcés-RedondoDepartment of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Olga CarmonaDepartment of Neurology, Fundació Salut Empordà, Figueres, Spain.
Laura Gabaldón-TorresDepartment of Neurology, Hospital Francesc de Borja, Gandía, Spain.
Lucía ForeroDepartment of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Mariona HervásDepartment of Neurology, Consorci Corporació Sanitària Parc Taulí, Sabadell, Spain.
Tamara Castillo-TriviñoDepartment of Neurology, Hospital Universitario Donostia, San Sebastián, Spain.
Jorge MaurinoMedical Department, Roche Farma, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple sclerosis is one of the most common causes of neurological disability in young adults, with major consequences for their future lives. Patients with early-stage relapsing-remitting multiple sclerosis (RRMS) experience uncertainty and intense emotions as the diagnosis is disclosed. Illness perception at this point can influence levels of adjustment, coping strategies, treatment adherence, and well-being of the patient. However, there is limited information on patient illness perception surrounding the diagnosis. Objective: The aim of this study was to assess illness perception and associated factors in early-stage RRMS patients. Methods: A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration of ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0-5.5 were included. The Brief-Illness Perception Questionnaire (B-IPQ) was used to assess the patients' cognitive and emotional representations of their illness. Different patient-reported measures were used to gather information on pain, fatigue, mood/anxiety, quality of life, symptom severity, feelings of hopelessness, perception of stigma, cognition, hand dexterity, gait, and workplace difficulties. A multivariate logistic regression analysis was performed to assess the association between the patients' illness perception and demographic and clinical characteristics, as well as patient-reported outcomes. Results: A total of 189 patients were included (mean age: 36.1 ± 9.4 years, 71.4% females, mean disease duration: 1.4 ± 0.8 years). The median EDSS score was 1.0 (interquartile range: 0.0-2.0). A total of 36.5% of the patients (n=69/189) had a moderate-to-high threatening illness perception, and 45.5% thought that their disease was caused by psychological factors. Higher EDSS scores, symptom severity, poorer psychological quality of life, perception of stigma, and greater hopelessness were predictors of moderate-to-high threatening illness perception. Conclusions: Threatening illness perceptions are common among patients with early-stage RRMS. Identifying these beliefs and their associated factors, and establishing individualized interventions, may help patients deal with their condition.

Indexed as

early-stageillness perceptionindividualized interventionspatient-reported outcome measurespsychological factorsrelapsing-remitting multiple sclerosis

Identifiers

PMID40698047
PMCPMC12279862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.